Loading…
Mangalam Organics (MANORG)₹439.10−0.44%Commodity Chemicals
In the Jun 2026 quarter (consolidated), Mangalam Organics reported sales of ₹179 Cr, up 22.3% from Jun 2025, and net profit of ₹7.29 Cr, down 40.5% year on year. For the year to Mar 2026, sales were ₹623 Cr and net profit ₹26.08 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 169 | 111 | 105 | 118 | 138 | 124 | 150 | 146 | 158 | 164 | 154 | 179 |
| Expenses | 159 | 100 | 94.55 | 107 | 126 | 108 | 130 | 125 | 157 | 145 | 107 | 156 |
| Operating Profit | 9.58 | 9.95 | 10.17 | 10.83 | 12.28 | 15.64 | 19.59 | 21.51 | 0.27 | 19.21 | 46.44 | 22.12 |
| OPM % | 5.7% | 9.0% | 9.6% | 9.2% | 8.9% | 12.6% | 13.1% | 14.7% | 0.2% | 11.7% | 30.3% | 12.4% |
| Other Income | 0.06 | 0.03 | 0.24 | 0.20 | 0.10 | 0.00 | 0.00 | 4.03 | 16.97 | 0.00 | −19.78 | 0.07 |
| Interest | 3.80 | 3.81 | 3.68 | 3.93 | 4.15 | 5.82 | 7.54 | 5.72 | 6.98 | 8.05 | 7.37 | 7.41 |
| Depreciation | 5.14 | 5.19 | 5.10 | 5.06 | 5.20 | 5.06 | 5.54 | 5.23 | 6.14 | 5.76 | 10.48 | 6.17 |
| Profit before tax | 0.75 | 1.04 | 1.69 | 2.10 | 3.11 | 4.86 | 6.62 | 14.74 | 4.19 | 5.50 | 8.99 | 8.73 |
| Tax % | 14.8% | 12.6% | −45.3% | 20.1% | 30.6% | 24.8% | 22.1% | 16.6% | 23.1% | 20.9% | 33.1% | 16.4% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.68 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.64 | 0.91 | 2.46 | 1.68 | 2.16 | 3.65 | 5.16 | 12.25 | 3.22 | 4.34 | 6.00 | 7.29 |
| EPS (Rs) | 0.73 | 1.04 | 2.85 | 1.94 | 2.50 | 4.24 | 5.99 | 14.26 | 3.74 | 5.05 | 6.97 | 8.48 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 375 | 338 | 491 | 493 | 494 | 530 | 623 | 655 |
| Expenses | 287 | 209 | 399 | 494 | 453 | 469 | 533 | 565 |
| Operating Profit | 85.61 | 127 | 90.63 | −2.99 | 38.84 | 58.78 | 87.61 | 88.04 |
| OPM % | 22.9% | 37.9% | 19.0% | −0.6% | 7.9% | 10.9% | 13.9% | 13.4% |
| Other Income | −8.98 | 0.99 | 0.99 | 0.00 | 0.99 | 0.00 | 0.99 | −2.74 |
| Interest | 4.99 | 0.99 | 3.99 | 13.97 | 15.96 | 20.97 | 27.93 | 29.81 |
| Depreciation | 9.01 | 14.01 | 15.03 | 18.03 | 20.04 | 21.04 | 28.03 | 28.55 |
| Profit before tax | 63.16 | 114 | 73.26 | −34.14 | 4.02 | 17.07 | 33.12 | 27.41 |
| Tax % | 23.9% | 25.9% | 26.9% | −19.1% | −8.1% | 24.0% | 22.9% | — |
| Exceptional items | −8.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.99 | −2.68 |
| Net Profit | 48.15 | 85.16 | 54.13 | −27.05 | 4.01 | 13.04 | 26.08 | 20.85 |
| EPS (Rs) | 55.90 | 98.95 | 62.66 | −31.76 | 5.14 | 14.70 | 30.05 | 24.24 |
| Dividend payout % | 2.0% | 2.0% | 2.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8.99 | 9.00 | 9.00 | 9.00 | 9.00 | 8.99 | 8.99 |
| Reserves | 159 | 242 | 295 | 267 | 272 | 284 | 309 |
| Borrowings | 19.94 | 23.95 | 212 | 190 | 173 | 271 | 358 |
| Other Liabilities | 27.13 | 35.17 | 44.21 | 40.18 | 31.15 | 58.22 | 62.30 |
| Total Liabilities | 215 | 311 | 559 | 505 | 484 | 623 | 739 |
| Fixed Assets | 102 | 121 | 198 | 227 | 244 | 269 | 328 |
| CWIP | 3.01 | 0.00 | 8.02 | 1.01 | 5.01 | 26.06 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 110 | 190 | 353 | 276 | 235 | 327 | 409 |
| Inventories | 64.94 | 106 | 244 | 189 | 136 | 213 | 300 |
| Trade receivables | 30.98 | 34.01 | 44.01 | 46.98 | 55.97 | 69.06 | 58.99 |
| Cash & equivalents | 0.99 | 33.93 | 0.99 | 0.99 | 1.99 | 0.99 | 2.99 |
| Total Assets | 215 | 311 | 559 | 505 | 484 | 623 | 739 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 92.70 | 25.92 | −83.74 | 76.82 | 72.84 | −7.97 | 0.99 |
| Cash from investing activity | −59.16 | −28.11 | −100 | −41.10 | −40.15 | −67.25 | −60.19 |
| Cash from financing activity | −36.08 | 2.01 | 183 | −36.08 | −33.07 | 74.24 | 60.12 |
| Net cash flow | −1.99 | 0.00 | −0.99 | 0.99 | 0.99 | −0.99 | 0.99 |
| Capex | 59.01 | 28.96 | 99.99 | 40.98 | 39.99 | 66.99 | 62.96 |
| Free cash flow | 34.02 | −2.99 | −184 | 36.01 | 33.01 | −75.01 | −58.98 |
| CFO / OP % | 128.0% | 44.0% | −68.0% | −2,786.0% | 178.0% | −13.0% | 4.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 31 | 37 | 33 | 35 | 41 | 48 | 34 |
| Inventory days | 113 | 314 | 321 | 201 | 164 | 285 | 334 |
| Days payable | 19 | 70 | 42 | 34 | 27 | 62 | 50 |
| Cash conversion cycle | 123 | 279 | 310 | 201 | 176 | 268 | 316 |
| Working capital days | 72 | 110 | 109 | 56 | 31 | 17 | 27 |
| ROCE % | — | 50.0% | 20.1% | −4.0% | 4.0% | 7.0% | 10.0% |
For the Jun 2026 quarter, Mangalam Organics reported sales of ₹179 Cr, up 22.3% year on year and net profit of ₹7.29 Cr, down 40.5% year on year. The operating margin was 12.4%.
Mangalam Organics' sales for the year to Mar 2026 were ₹623 Cr; over the last twelve months they were ₹655 Cr.
Net profit for the year to Mar 2026 was ₹26.08 Cr, and ₹20.85 Cr over the last twelve months. Earnings per share over the same trailing period were ₹24.24.
Mangalam Organics reported borrowings of ₹358 Cr at Mar 2026, against cash and equivalents of ₹2.99 Cr.
Cash from operations was ₹0.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹58.98 Cr.